Walleye Capital LLC United Therapeutics Corp Put Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $1.03 Million - $1.2 Million
3,300 Added 32.35%
13,500 $4.84 Million
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $844,562 - $1.18 Million
3,700 Added 56.92%
10,200 $3.25 Million
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $906,268 - $1.07 Million
4,300 Added 195.45%
6,500 $1.49 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $150,416 - $179,858
-700 Reduced 24.14%
2,200 $483,000
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $508,368 - $595,776
2,400 Added 480.0%
2,900 $655,000
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $102,595 - $116,495
500 New
500 $110,000
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $700,230 - $953,462
3,400 Added 680.0%
3,900 $1.08 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $101,650 - $122,085
500 New
500 $105,000
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $690,693 - $1 Million
-8,700 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $391,550 - $476,700
5,000 Added 135.14%
8,700 $766,000
Q3 2019

Nov 14, 2019
BUY
$74.85 - $85.99 $142,215 - $163,381
1,900 Added 105.56%
3,700 $295,000
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $22,818 - $36,243
300 Added 20.0%
1,800 $141,000
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $160,725 - $190,260
1,500 New
1,500 $176,000

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email